Iron metabolism in obesity and metabolic syndrome
Á González-Domínguez, FM Visiedo-García… - International journal of …, 2020 - mdpi.com
Obesity is an excessive adipose tissue accumulation that may have detrimental effects on
health. Particularly, childhood obesity has become one of the main public health problems in …
health. Particularly, childhood obesity has become one of the main public health problems in …
Regulation of drug transport proteins—From mechanisms to clinical impact: A white paper on behalf of the international transporter consortium
Membrane transport proteins are involved in the absorption, disposition, efficacy, and/or
toxicity of many drugs. Numerous mechanisms (eg, nuclear receptors, epigenetic gene …
toxicity of many drugs. Numerous mechanisms (eg, nuclear receptors, epigenetic gene …
Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice
Y Guo, Y Yu, H Li, X Ding, X Li, X Jing, J Chen… - European journal of …, 2021 - Springer
Purpose Inulin is a type of fermentable dietary fiber, which is non-digestible, and can
improve metabolic function by modulating intestinal microbiota. This study aimed to evaluate …
improve metabolic function by modulating intestinal microbiota. This study aimed to evaluate …
Effects of bacterial and viral pathogen-associated molecular patterns (PAMPs) on multidrug resistance (MDR) transporters in brain endothelial cells of the developing …
P Lye, E Bloise, SG Matthews - Fluids and Barriers of the CNS, 2023 - Springer
Background The multidrug resistance (MDR) transporters, P-glycoprotein (P-gp, encoded by
ABCB1) and breast cancer resistance protein (BCRP/ABCG2) contribute to the blood–brain …
ABCB1) and breast cancer resistance protein (BCRP/ABCG2) contribute to the blood–brain …
[HTML][HTML] Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapies
Drug-induced liver injury (DILI) is one of the most frequent sources of liver failure and the
leading cause of liver transplant. Common non-prescription medications such as non …
leading cause of liver transplant. Common non-prescription medications such as non …
Managing cancer drug resistance from the perspective of inflammation
S Lu, Y Li, C Zhu, W Wang, Y Zhou - Journal of oncology, 2022 - Wiley Online Library
The development of multidrug resistance in cancer chemotherapy is a major obstacle to the
effective treatment of human malignant tumors. Several epidemiological studies have …
effective treatment of human malignant tumors. Several epidemiological studies have …
Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity
K Alim, A Bruyère, A Lescoat, E Jouan… - Expert opinion on …, 2021 - Taylor & Francis
ABSTRACT Introduction: Janus kinase inhibitors (JAKinibs) constitute an emerging and
promising pharmacological class of anti-inflammatory or anti-cancer drugs, used notably for …
promising pharmacological class of anti-inflammatory or anti-cancer drugs, used notably for …
Mucosal epithelial Jak kinases in health and diseases
N Kumar, L Kuang, R Villa, P Kumar… - Mediators of …, 2021 - Wiley Online Library
Janus kinases (Jaks) are a family of nonreceptor tyrosine kinase that include four different
members, viz., Jak1, Jak2, Jak3, and Tyk2. Jaks play critical roles in immune cells functions; …
members, viz., Jak1, Jak2, Jak3, and Tyk2. Jaks play critical roles in immune cells functions; …
Polyphenol from millet bran increases the sensitivity of colorectal cancer cells to oxaliplatin by blocking the ganglioside GM3 catabolism
X Zhang, S Shan, J Shi, H Li, Z Li - Food & function, 2021 - pubs.rsc.org
Colorectal cancer (CRC) is an aggressive malignancy with very limited therapeutic
approaches. Drug resistance develops as a frequent characteristic in many patients with …
approaches. Drug resistance develops as a frequent characteristic in many patients with …
Regulation of ABC transporters by sex steroids may explain differences in drug resistance between sexes
Drug efficacy is dependent on the pharmacokinetics and pharmacodynamics of therapeutic
agents. Tight junctions, detoxification enzymes, and drug transporters, due to their …
agents. Tight junctions, detoxification enzymes, and drug transporters, due to their …